Inhibikase Therapeutics, Inc.
IKT • NASDAQ
Inhibikase Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Garth Lees-Rolfe, with a market cap of $186.8M. As of Q3 2025, 74% of shares are held by 53 institutional investors, with Sands Capital Ventures, LLC as the largest holder at 14.69%.
Chief Executive OfficerGarth Lees-Rolfe
Market Cap$186.8M
Biotechnology
Healthcare
Employees9.0
Websiteinhibikase.com
Country
United States of America
Overview
Overview of institutional ownership in IKT as of Q3 2025 with a market cap of $120.7M
All Institutions
- Institutions
- 53
- Value Held
- $89.0M
- Shares Held
- 55.0M
- Avg Position
- $1.7M
- Median Position
- $77.6K
Hedge Funds
- Hedge Funds
- 7
- Value Held
- $49.9M
- Shares Held
- 30.8M
- Avg Position
- $7.1M
- Median Position
- $8.7M
Ownership Breakdown
Based on market cap of $120.7M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Biggest Investors
Institutions with the largest positions in IKT as of Q3 2025
| Institution | Position Value |
|---|---|
 Sands Capital Ventures, LLC Venture Capital | $17.7M 3.89% of portfolio |
 Soleus Capital Management, L.P. Hedge Fund•Long/Short | $10.2M 0.56% of portfolio |
 Fairmount Funds Management LLC Hedge Fund•Sector | $9.9M 0.89% of portfolio |
 PERCEPTIVE ADVISORS LLC Hedge Fund•Long/Short | $8.8M 0.25% of portfolio |
 COMMODORE CAPITAL LP Hedge Fund•Long/Short | $8.7M 0.43% of portfolio |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | $8.5M 0.86% of portfolio |
 VANGUARD GROUP INC Institution | $5.3M 0.00% of portfolio |
B BlackRock, Inc. Institution | $5.0M 0.00% of portfolio |
 Blackstone Group L.P. Institution | $4.3M 0.02% of portfolio |
N Nantahala Capital Management, LLC Hedge Fund•Multi-Strategy | $3.5M 0.22% of portfolio |
Net Capital Flow
Institutional buying and selling activity for IKT in Q3 2025
- Traded
- +$755.8K
- Buyers
- 24
- Sellers
- 16
- Total Bought
- +$1.6M
- Total Sold
- −$888.2K
- Avg Position
- $1.6M
Biggest Buyers
| Institution | Net Bought |
|---|---|
B BlackRock, Inc. Institution | +$562.2K +347.0K shares |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | +$203.3K +125.5K shares |
 STATE STREET CORP Institution | +$178.1K +109.9K shares |
 UBS Group AG Institution | +$158.1K +97.6K shares |
 DEUTSCHE BANK AG\ Institution | +$130.4K +80.5K shares |
 CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | +$116.1K +71.7K shares |
VANGUARD GROUP INC Institution | +$79.3K +49.0K shares |
 GEODE CAPITAL MANAGEMENT LLC ETF Provider | +$74.3K +45.9K shares |
 JPMORGAN CHASE & CO Institution | +$34.6K +21.4K shares |
V Virtu Financial LLC Institution | +$21.8K +13.4K shares |
Biggest Sellers
| Institution | Net Sold |
|---|---|
 SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | −$546.7K −337.5K shares |
 MORGAN STANLEY RIA/Wealth | −$70.7K −43.7K shares |
 FMR LLC Institution | −$62.3K −38.5K shares |
L LMR Partners LLP Institution | −$60.6K −31.1K shares |
 BARCLAYS PLC Institution | −$40.0K −24.7K shares |
 NORTHERN TRUST CORP Institution | −$29.8K −18.4K shares |
N NEW YORK STATE COMMON RETIREMENT FUND Institution | −$20.7K −12.8K shares |
PERCEPTIVE ADVISORS LLC Hedge Fund•Long/Short | −$17.4K −10.7K shares |
 ING INVESTMENT MANAGEMENT LLC Insurance Manager | −$9.1K −5.6K shares |
M MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Institution | −$8.2K −5.1K shares |
Entry and Exit Activity
Institutions that initiated new positions or completely exited IKT in Q3 2025
- New Positions
- 5
- New Value
- $143.2K
- Exited Positions
- 2
- Exited Value
- $62.6K
New Positions
| Institution | Position Value |
|---|---|
DEUTSCHE BANK AG\ Institution | $130.4K 80.5K shares |
R Russell Investments Group, Ltd. RIA/Wealth | $12.5K 7.7K shares |
 PNC FINANCIAL SERVICES GROUP, INC. Institution | $146.0 90.0 shares |
 SRS Capital Advisors, Inc. RIA/Wealth | $139.0 86.0 shares |
 CWM, LLC RIA/Wealth | - 19.0 shares |
Exited Positions
| Institution | Previous Position |
|---|---|
L LMR Partners LLP Institution | $60.6K 31.1K shares |
 RAYMOND JAMES FINANCIAL INC RIA/Wealth | $2.0K 1.0K shares |
Options Activity
Institutions with the largest Call and Put options positions in IKT as of Q3 2025
- Call Positions
- 0
- Call Value
- -
- Put Positions
- 0
- Put Value
- -
Call Positions
| Institution | Position Value |
|---|---|
| No call positions found | |
Put Positions
| Institution | Position Value |
|---|---|
| No put positions found | |
Most Committed Institutions
Institutions with IKT as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
Sands Capital Ventures, LLC Venture Capital | 3.89% $17.7M |
S Stonepine Capital Management, LLC Institution | 0.97% $1.2M |
Fairmount Funds Management LLC Hedge Fund•Sector | 0.89% $9.9M |
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short | 0.86% $8.5M |
Soleus Capital Management, L.P. Hedge Fund•Long/Short | 0.56% $10.2M |
COMMODORE CAPITAL LP Hedge Fund•Long/Short | 0.43% $8.7M |
PERCEPTIVE ADVISORS LLC Hedge Fund•Long/Short | 0.25% $8.8M |
N Nantahala Capital Management, LLC Hedge Fund•Multi-Strategy | 0.22% $3.5M |
C CAXTON CORP Institution | 0.12% $26.6K |
Blackstone Group L.P. Institution | 0.02% $4.3M |
Hedge Fund Spotlight
Discover hedge funds investing in IKT
COMMODORE CAPITAL LP
Hedge Fund • Long/Short
Portfolio ManagerMichael Jonathan Kramarz
- Portfolio Value
- $2.0B
- Positions
- 37
- Last Reported
- Q3 2025
Sector Allocation
Position in Inhibikase Therapeutics, Inc.
- Market Value
- $8.7M
- Shares Held
- 5.4M
- Portfolio Weight
- 0.43%
- Owned Since
- 2024-Q4
| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $331.9M | 16.20% | |
Biotechnology Healthcare | $121.1M | 5.91% | |
Biotechnology Healthcare | $108.4M | 5.29% |
